Cargando…
Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis
A mouthwash formulation of rebamipide (REB) is commonly used to treat oral mucositis; however, this formulation does not provide sufficient treatment or prevention in cases of serious oral mucositis. To improve treatment, we attempted to design a hydrogel incorporating REB nanocrystals (R-NPs gel)....
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356607/ https://www.ncbi.nlm.nih.gov/pubmed/32527029 http://dx.doi.org/10.3390/pharmaceutics12060532 |
_version_ | 1783558528395378688 |
---|---|
author | Nagai, Noriaki Seiriki, Ryotaro Deguchi, Saori Otake, Hiroko Hiramatsu, Noriko Sasaki, Hiroshi Yamamoto, Naoki |
author_facet | Nagai, Noriaki Seiriki, Ryotaro Deguchi, Saori Otake, Hiroko Hiramatsu, Noriko Sasaki, Hiroshi Yamamoto, Naoki |
author_sort | Nagai, Noriaki |
collection | PubMed |
description | A mouthwash formulation of rebamipide (REB) is commonly used to treat oral mucositis; however, this formulation does not provide sufficient treatment or prevention in cases of serious oral mucositis. To improve treatment, we attempted to design a hydrogel incorporating REB nanocrystals (R-NPs gel). The R-NPs gel was prepared by a bead mill method using carbopol hydrogel, methylcellulose and 2-hydroxypropyl-β-cyclodextrin, and another hydrogel incorporating REB microcrystals (R-MPs gel) was prepared following the same protocol but without the bead mill treatment. The REB particle size in the R-MPs gel was 0.15–25 μm, and while the REB particle size was 50–180 nm in the R-NPs gel. Next, we investigated the therapeutic effect of REB nanocrystals on oral mucositis using a hamster model. Almost all of the REB was released as drug nanocrystals from the R-NPs gel, and the REB content in the cheek pouch of hamsters treated with R-NPs gel was significantly higher than that of hamsters treated with R-MPs gel. Further, treatment with REB hydrogels enhanced the healing of oral wounds in the hamsters. REB accumulation in the cheek pouch of hamsters treated with the R-NPs gel was prevented by an inhibitor of clathrin-dependent endocytosis (CME) (40 μM dynasore). In conclusion, we designed an R-NPs gel and found that REB nanocrystals are taken up by tissues through CME, where they provide a persistent effect resulting in an enhancement of oral wound healing. |
format | Online Article Text |
id | pubmed-7356607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73566072020-07-22 Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis Nagai, Noriaki Seiriki, Ryotaro Deguchi, Saori Otake, Hiroko Hiramatsu, Noriko Sasaki, Hiroshi Yamamoto, Naoki Pharmaceutics Article A mouthwash formulation of rebamipide (REB) is commonly used to treat oral mucositis; however, this formulation does not provide sufficient treatment or prevention in cases of serious oral mucositis. To improve treatment, we attempted to design a hydrogel incorporating REB nanocrystals (R-NPs gel). The R-NPs gel was prepared by a bead mill method using carbopol hydrogel, methylcellulose and 2-hydroxypropyl-β-cyclodextrin, and another hydrogel incorporating REB microcrystals (R-MPs gel) was prepared following the same protocol but without the bead mill treatment. The REB particle size in the R-MPs gel was 0.15–25 μm, and while the REB particle size was 50–180 nm in the R-NPs gel. Next, we investigated the therapeutic effect of REB nanocrystals on oral mucositis using a hamster model. Almost all of the REB was released as drug nanocrystals from the R-NPs gel, and the REB content in the cheek pouch of hamsters treated with R-NPs gel was significantly higher than that of hamsters treated with R-MPs gel. Further, treatment with REB hydrogels enhanced the healing of oral wounds in the hamsters. REB accumulation in the cheek pouch of hamsters treated with the R-NPs gel was prevented by an inhibitor of clathrin-dependent endocytosis (CME) (40 μM dynasore). In conclusion, we designed an R-NPs gel and found that REB nanocrystals are taken up by tissues through CME, where they provide a persistent effect resulting in an enhancement of oral wound healing. MDPI 2020-06-09 /pmc/articles/PMC7356607/ /pubmed/32527029 http://dx.doi.org/10.3390/pharmaceutics12060532 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nagai, Noriaki Seiriki, Ryotaro Deguchi, Saori Otake, Hiroko Hiramatsu, Noriko Sasaki, Hiroshi Yamamoto, Naoki Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis |
title | Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis |
title_full | Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis |
title_fullStr | Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis |
title_full_unstemmed | Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis |
title_short | Hydrogel Formulations Incorporating Drug Nanocrystals Enhance the Therapeutic Effect of Rebamipide in a Hamster Model for Oral Mucositis |
title_sort | hydrogel formulations incorporating drug nanocrystals enhance the therapeutic effect of rebamipide in a hamster model for oral mucositis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356607/ https://www.ncbi.nlm.nih.gov/pubmed/32527029 http://dx.doi.org/10.3390/pharmaceutics12060532 |
work_keys_str_mv | AT nagainoriaki hydrogelformulationsincorporatingdrugnanocrystalsenhancethetherapeuticeffectofrebamipideinahamstermodelfororalmucositis AT seirikiryotaro hydrogelformulationsincorporatingdrugnanocrystalsenhancethetherapeuticeffectofrebamipideinahamstermodelfororalmucositis AT deguchisaori hydrogelformulationsincorporatingdrugnanocrystalsenhancethetherapeuticeffectofrebamipideinahamstermodelfororalmucositis AT otakehiroko hydrogelformulationsincorporatingdrugnanocrystalsenhancethetherapeuticeffectofrebamipideinahamstermodelfororalmucositis AT hiramatsunoriko hydrogelformulationsincorporatingdrugnanocrystalsenhancethetherapeuticeffectofrebamipideinahamstermodelfororalmucositis AT sasakihiroshi hydrogelformulationsincorporatingdrugnanocrystalsenhancethetherapeuticeffectofrebamipideinahamstermodelfororalmucositis AT yamamotonaoki hydrogelformulationsincorporatingdrugnanocrystalsenhancethetherapeuticeffectofrebamipideinahamstermodelfororalmucositis |